5HLF image
Entry Detail
PDB ID:
5HLF
Title:
STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE In COMPLEX WITH A 38-MER HAIRPIN TEMPLATE-PRIMER DNA APTAMER AND AN ALPHA-CARBOXYPHOSPHONATE INHIBITOR
Biological Source:
PDB Version:
Deposition Date:
2016-01-15
Release Date:
2016-02-10
Method Details:
Experimental Method:
Resolution:
2.95 Å
R-Value Free:
0.25
R-Value Work:
0.20
R-Value Observed:
0.21
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:HIV-1 REVERSE TRANSCRIPTASE P66 SUBUNIT
Mutations:D498N
Chain IDs:A, C
Chain Length:555
Number of Molecules:2
Biological Source:Human immunodeficiency virus type 1 group M subtype B (isolate BH10)
Polymer Type:polypeptide(L)
Description:HIV-1 REVERSE TRANSCRIPTASE P51 SUBUNIT
Chain IDs:B, D
Chain Length:444
Number of Molecules:2
Biological Source:Human immunodeficiency virus type 1 group M subtype B (isolate BH10)
Polymer Type:polydeoxyribonucleotide
Description:DNA (38-MER)
Chain IDs:E, F
Chain Length:38
Number of Molecules:2
Biological Source:synthetic construct
Peptide-like Molecules
PRD_900003
Primary Citation
Exploring the role of the alpha-carboxyphosphonate moiety in the HIV-RT activity of alpha-carboxy nucleoside phosphonates.
Org.Biomol.Chem. 14 2454 2465 (2016)
PMID: 26813581 DOI: 10.1039/c5ob02507a

Abstact

As α-carboxy nucleoside phosphonates (α-CNPs) have demonstrated a novel mode of action of HIV-1 reverse transcriptase inhibition, structurally related derivatives were synthesized, namely the malonate 2, the unsaturated and saturated bisphosphonates 3 and 4, respectively and the amide 5. These compounds were evaluated for inhibition of HIV-1 reverse transcriptase in cell-free assays. The importance of the α-carboxy phosphonoacetic acid moiety for achieving reverse transcriptase inhibition, without the need for prior phosphorylation, was confirmed. The malonate derivative 2 was less active by two orders of magnitude than the original α-CNPs, while displaying the same pattern of kinetic behavior; interestingly the activity resides in the “L”-enantiomer of 2, as seen with the earlier series of α-CNPs. A crystal structure with an RT/DNA complex at 2.95 Å resolution revealed the binding of the “L”-enantiomer of 2, at the polymerase active site with a weaker metal ion chelation environment compared to 1a (T-α-CNP) which may explain the lower inhibitory activity of 2.

Legend

Protein

Chemical

Disease

Primary Citation of related structures